8-K//Current report
Adamas Pharmaceuticals Inc 8-K
Accession 0001328143-21-000072
CIK 0001328143operating
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 4:04 PM ET
Size
260.7 KB
Accession
0001328143-21-000072
Documents
- 8-Kadms-20210809.htmPrimary
8-K
- EX-99.1adms991q22021earningsrelea.htm
EX-99.1
- EX-101.SCHadms-20210809.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABadms-20210809_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PREadms-20210809_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- XMLadms-20210809_htm.xml
IDEA: XBRL DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001328143-21-000072-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001328143
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 4:04 PM ET
- Size
- 260.7 KB